Novocure Receives MHLW Approval for Second Generation OptuneĀ® in Japan
Go back to Novocure Receives MHLW Approval for Second Generation OptuneĀ® in Japan| (NASDAQ: NVCR) | Delayed: 17.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.53 | 52 Week High | $28.95 | |||
| Open | $17.53 | 52 Week Low | $5.95 | |||
| Day High | $17.53 | P/E | N/A | |||
| Day Low | $17.53 | EPS | $0.00 | |||
| Volume | 1 | |||||

